Advances and mechanisms of hydrogel-based interventions for intervertebral disc degeneration repair
Biomedical Materials · 01.06.2026 · 21 (3) · 032001
DOI: 10.1088/1748-605x/ae5ee6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomedical Materials, online erschienen am 04.05.2026. Verfasst von Wen Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical and Basic Medical Sciences, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical Univers…. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Hydrogels, Biocompatible Materials. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Shandong Province Medical and Health Technology Project, Innovation Ability Improvement Project of Scientific and Technological Company Shandong Province, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is a leading cause of low back pain and remains difficult to treat because of its progressive pathology, complex microenvironment, and limited intrinsic repair capacity. Conventional conservative therapies rarely prevent degeneration, while surgical interventions fail to restore disc biology and are associated with substantial complications. These challenges have motivated increasing interest in biomaterial-based therapeutic strategies. Hydrogels have emerged as adaptable platforms for IVDD intervention owing to their injectability, tunable mechanical properties, and biocompatibility. By functioning as supportive scaffolds and delivery systems for cells, bioactive factors, or drugs, hydrogel-based approaches can modulate inflammation, regulate extracellular matrix metabolism, and stabilize the disc microenvironment. This review critically examines recent advances in hydrogel-based strategies for IVDD, emphasizing the interplay between material design. Key limitations and translational considerations are discussed to guide the rational development of hydrogel systems that support structural and functional repair of degenerated intervertebral discs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Clinical and Basic Medical Sciences, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong Province…
- School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong Province 250117, People's Republic of China.
- Department of Stomatology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji'nan, Shandong Province 250021, People's Republic of China.
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong Province 250117, People's Republic of China.
ORCID-Profile: Ningbo Li, Dandan Wang
Förderung
- Shandong Province Medical and Health Technology Project
- Innovation Ability Improvement Project of Scientific and Technological Company Shandong Province
- Postdoctoral Research Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Luo, W., Li, H., Chen, X., Wang, P., Li, N., & Wang, D. (2026). Advances and mechanisms of hydrogel-based interventions for intervertebral disc degeneration repair. Biomedical Materials, 21(3), 032001. https://doi.org/10.1088/1748-605x/ae5ee6
Vancouver
Luo W, Li H, Chen X, Wang P, Li N, Wang D. Advances and mechanisms of hydrogel-based interventions for intervertebral disc degeneration repair. Biomedical Materials. 2026;21(3):032001. doi:10.1088/1748-605x/ae5ee6
BibTeX
@article{Luo2026,
author = {Luo, Wen and Li, Huiying and Chen, Xiangyuan and Wang, Ping and Li, Ningbo and Wang, Dandan},
title = {Advances and mechanisms of hydrogel-based interventions for intervertebral disc degeneration repair},
journal = {Biomedical Materials},
year = {2026},
volume = {21},
number = {3},
pages = {032001},
doi = {10.1088/1748-605x/ae5ee6}
}
EUVIMED